| BioID | bio97983 |
|---|
| Name | VALSARTAN |
|---|
| ChEMBL ID | CHEMBL1069 |
|---|
| Molecular Formula | C24H29N5O3 |
|---|
| Molecular Weight | 435.53 |
|---|
| Molecular Weight (Monoisotopic) | 435.227 |
|---|
| Type | Small molecule |
|---|
| Max Phase | Phase 4 |
|---|
| Target ID | Tar53 |
|---|
| Target Name | None |
|---|
| Synonyms | CGP 48933|CGP-48933|DIOVAN|Exforge|NSC-758927|PREXXARTAN|VALSARTAN |
|---|
| Smiles | CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C |
|---|
| Inchi | InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1 |
|---|
| Inchi Key | ACWBQPMHZXGDFX-QFIPXVFZSA-N |
|---|
| Molecular Species | ACID |
|---|
| Targets | 172.0 |
|---|
| Bioactivities | 2162.0 |
|---|
| Np Likeness Score | -0.98 |
|---|
| Records Key | ['valsartan', 'Valsartan', 'Valsartan', 'Valsartan', '4e (valsartan)', 'valsartan', 'Valsartan', 'CGP-48933', 'Valsartan', 'SID26719825', 'Valsartan', 'valsartan', 'Valsartan', 'Valsartan', 'Valsartan', 'Valsartan', '112', 'valsartan', 'valsartan', '189, CGP-48933', '375', 'Valsartan', 'Valsartan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'Co-diovan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'Valsartan', 'Valsartan', 'VALSARTAN', 'valsartan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', '1764', 'COVC-0136525573', 'Valsartan', 'VALSARTAN', 'Valsartan', 'Valsartan', 'VALSARTAN', 'Valsartan', 'Valsartan', 'VALSARTAN', 'valsartan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'VALSARTAN', 'SAM001246581', 'VALSARTAN', 'Valsartan', '8', 'EUB0000762a', 'EUB0000762a', 'EUB0000762a', 'EUB0000762a', 'Valsartan', 'Valsartan', 'Valsartan'] |
|---|
| Records Name | [3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]-amino}-butyric acid", 'Valsartan', 'Valsartan', "(S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid", "(S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid", "2-{[2'-(2,3-Dihydro-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid", 'Valsartan', "(S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid", "3-Methyl-2-{((S)-pentanoyl)-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid", 'SID26719825', 'Valsartan', "(S)-3-Methyl-2-{pentanoyl-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid", 'Valsartan', 'Valsartan', 'Valsartan', 'Valsartan', 'Valsartan', 'valsartan', 'valsartan', "(S)-2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid", 'Valsartan', 'Valsartan', 'Valsartan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'Co-diovan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'Valsartan', 'Valsartan', 'Valsartan', 'valsartan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', None, 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'Valsartan', 'Valsartan', 'VALSARTAN', 'Valsartan', 'Valsartan', 'VALSARTAN', 'valsartan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'Valsartan', 'VALSARTAN', 'VALSARTAN', 'C0164711', 'VALSARTAN', 'Valsartan', 'Valsartan', 'VALSARTAN', 'VALSARTAN', 'VALSARTAN', 'VALSARTAN', 'Valsartan', 'Valsartan', 'Valsartan']" |
|---|
| Withdrawn Flag | False |
|---|
| Orphan | 0 |
|---|
